Interaction of SPP1 and its receptor CD47 further inhibits angiogenesis by antagonizing nitric oxide signaling in endothelial and vascular smooth muscle cells which, in turn, affects the tumor microenvironment [42]. Here, SPP1 is linked to neoplasm.